Metrics
187,706 Downloads
Contact Share
heiDATA is an institutional repository for Open Research Data from Heidelberg University. It is managed by Heidelberg University's Research Data Unit, a joint institution of the University Library and the Computing Centre. If you are interested in publishing your data here, please have a look at our user guide and get in touch with us. Detailed information on heiDATA can be found in our service description.
Featured Dataverses

In order to use this feature you must have at least one published dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

2,931 to 2,940 of 8,903 Results
Vardarli_Suppl Fig 44.pdf
Vardarli_Suppl Fig 44.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 67.2 KB - MD5: cd781c30f0006a4ad7f171b926a376a0
Suppl. Fig. 44. Funnel plot for subgroups of ICI types trials investigating adrenal insufficiency grade3-5 under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl Fig 45.pdf
Vardarli_Suppl Fig 45.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 68.4 KB - MD5: d78f68109278d4cd9cce0b16cc721242
Suppl. Fig. 45. Funnel plot with trim-and-fill for trials investigating adrenal insufficiency grade3-5 under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl Fig 46.pdf
Vardarli_Suppl Fig 46.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 71.7 KB - MD5: 7e83c6d464b3338702449c8b9f24491b
Suppl. Fig. 46. Galbraith plot for trials investigating adrenal insufficiency grade 3-5 under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl Fig 47.pdf
Vardarli_Suppl Fig 47.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 64.8 KB - MD5: a8a02f96648251f36d57cec66aac29e1
Suppl. Fig. 47. Funnel plot for trials investigating insulin-dependent diabetes mellitus any grade under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl Fig 48.pdf
Vardarli_Suppl Fig 48.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 67.8 KB - MD5: 5dceec97c79e3c75b092b9a7c2cafa6c
Suppl. Fig. 48. Funnel plot for subgroups of ICI types trials investigating insulin-dependent diabetes mellitus any grade under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl Fig 49.pdf
Vardarli_Suppl Fig 49.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 69.0 KB - MD5: 7a808d3c389b01b8f49293d6bfed88ab
Suppl. Fig. 49. Funnel plot with trim-and-fill for trials investigating insulin-dependent diabetes mellitus any grade under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl Fig 4.pdf
Vardarli_Suppl Fig 4.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 81.0 KB - MD5: df108cf5375705ae0e54343a1fb8acac
Suppl. Fig. 4. Forest plot for cumulative meta-analysis for trials investigating hypothyroidism any grade under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl Fig 50.pdf
Vardarli_Suppl Fig 50.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 69.9 KB - MD5: d825677630916a539b655dd80f08f58c
Suppl. Fig. 50. Galbraith plot for trials investigating insulin-dependent diabetes mellitus any grade under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl Fig 51.pdf
Vardarli_Suppl Fig 51.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 64.0 KB - MD5: 62d2d0c1c5b14b535044b7a85fc57209
Suppl. Fig. 51. Funnel plot for trials investigating insulin-dependent diabetes mellitus grade3-5 under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl Fig 52.pdf
Vardarli_Suppl Fig 52.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 66.9 KB - MD5: b012d9a64cf579cb3aad487d43e2ae25
Suppl. Fig. 52. Funnel plot for subgroups of ICI types trials investigating insulin-dependent diabetes mellitus grade3-5 under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Add Data

Sign up or log in to create a dataverse or add a dataset.

Sign Up Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.